Hikal Limited (HIKAL)
ISIN: INE475B01022 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
382.5
-0.8(-0.21%)

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Pricing Updates

TODAY'S HIGH

392.05

TODAY'S LOW

380.95

52 WEEK HIGH

742

52 WEEK LOW

345.3

Major Holders

% of Shares Held by
All Insider

68.98%

% of Shares Held by
Institutions

9.00%

% of Float Held by
Institutions

29.01%

Number of Institutions
Holding Shares

18

Company Overview

MARKET CAP

4719.32 Cr.

ETERPRISE VALUE

5268.25 Cr.

NO. OF SHARES

12.33 Cr.

BOOK VALUE

82.233

DIV. YIELD

1.2%

DEBT

624.73 Cr.

GROSS PROFIT

772.81 Cr.

CASH

62.44 Cr.

REVENUE

1972.82 Cr.

REVENUE/SHARE

160.004

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments7.30 Lakhs7.30 Lakhs7.30 Lakhs-6.86 Cr.
Change To Liabilities29.25 Cr.37.25 Cr.-3 Cr.26.59 Cr.
Total cashflows from Investing Activities-156.19 Cr.-163.79 Cr.-124.59 Cr.-110.12 Cr.
Net Borrowings-33.26 Cr.-25.01 Cr.19.33 Cr.37.72 Cr.
Total Cash from Financing Activities-96.86 Cr.-100.86 Cr.-55.40 Cr.-24.79 Cr.
Other Liabilities20.40 Cr.-55.34 Cr.43.56 Cr.-44.75 Cr.
Total Assets0000
Net Income133.14 Cr.84.43 Cr.103.07 Cr.77.22 Cr.
Change in Cash-24.04 Cr.20.26 Cr.5.59 Cr.3.89 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities229.01 Cr.284.93 Cr.185.58 Cr.138.81 Cr.
Depreciation84.50 Cr.81.58 Cr.92.05 Cr.85.28 Cr.
Other Cashflows from Investing Activities1.33 Cr.-5.80 Cr.3.52 Cr.2.71 Cr.
Dividends Paid-14.81 Cr.-19.72 Cr.-13.56 Cr.-10.68 Cr.
Change to Inventory39.76 Cr.50.59 Cr.-61.17 Cr.-39.47 Cr.
Change to Account Receivables-147.32 Cr.13.98 Cr.-69.07 Cr.-29.52 Cr.
Other Cashflows from Financing Activities-48.78 Cr.-56.12 Cr.-61.17 Cr.-51.83 Cr.
Change to Net Income68.52 Cr.71.54 Cr.79.32 Cr.63.15 Cr.
Capital Expenditures-157.59 Cr.-158.03 Cr.-128.42 Cr.-105.98 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax206.42 Cr.126.57 Cr.149.08 Cr.111.49 Cr.
Minority InterestNoneNoneNoneNone
Net Income239.51 Cr.191.37 Cr.210.34 Cr.160.78 Cr.
Selling General Administrative168.09 Cr.160.37 Cr.138.83 Cr.130.03 Cr.
Gross Profit772.81 Cr.685.53 Cr.694.04 Cr.567.91 Cr.
Ebit239.51 Cr.191.37 Cr.210.34 Cr.160.78 Cr.
Operating Income239.51 Cr.191.37 Cr.210.34 Cr.160.78 Cr.
Other Operating Expenses279.96 Cr.251.32 Cr.251.98 Cr.191.49 Cr.
Interest Expense-31.94 Cr.-49.24 Cr.-54.86 Cr.-46.33 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense73.28 Cr.42.14 Cr.46 Cr.34.26 Cr.
Total Revenue1720.43 Cr.1507.26 Cr.1589.60 Cr.1296.09 Cr.
Total Operating Expenses1480.92 Cr.1315.89 Cr.1379.26 Cr.1135.30 Cr.
Cost of Revenue947.62 Cr.821.73 Cr.895.56 Cr.728.18 Cr.
Total Other Income Expense Net-33.08 Cr.-64.79 Cr.-61.25 Cr.-49.29 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.133.14 Cr.84.43 Cr.103.07 Cr.77.22 Cr.
Net Income Applicable to Common Shares133.14 Cr.84.43 Cr.103.07 Cr.77.22 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets10.25 Cr.10.85 Cr.8.24 Cr.5.83 Cr.
Capital Surplus6.47 Cr.6.47 Cr.38.12 Cr.46.34 Cr.
Total Liabilities979.81 Cr.951.47 Cr.929.28 Cr.872.32 Cr.
Stock Holder Equity933.41 Cr.816.51 Cr.756.21 Cr.669.38 Cr.
Minority Interest0000
Other Liabilities53.65 Cr.29.97 Cr.54.75 Cr.34.04 Cr.
Total Assets1913.23 Cr.1767.99 Cr.1685.49 Cr.1541.70 Cr.
Common Stock24.66 Cr.24.66 Cr.24.66 Cr.16.44 Cr.
Retained Earnings850.98 Cr.734.08 Cr.641.90 Cr.555.02 Cr.
Other Liabilities59.56 Cr.50.84 Cr.28.87 Cr.15.64 Cr.
Good Will0000
Treasury Stock51.30 Cr.51.30 Cr.51.52 Cr.51.57 Cr.
Other Assets67.21 Cr.96.50 Cr.62.80 Cr.97.67 Cr.
Cash7.63 Cr.31.68 Cr.11.41 Cr.5.82 Cr.
Current Liabilities656.77 Cr.596.31 Cr.602.57 Cr.560.04 Cr.
Long Term Asset Charges00045.90 Lakhs
Short Long Term Debt95.05 Cr.83.77 Cr.61.19 Cr.61.29 Cr.
Other Stockholder Equity51.30 Cr.51.30 Cr.51.52 Cr.51.57 Cr.
Property Plant Equipment956.54 Cr.885.18 Cr.783.40 Cr.745.63 Cr.
Total Cur. Assets878.60 Cr.774.76 Cr.830.02 Cr.689.95 Cr.
Long Term Investments62.20 Lakhs69 Lakhs1.02 Cr.2.60 Cr.
Net Tangible Assets923.16 Cr.805.66 Cr.747.96 Cr.663.54 Cr.
Short Term Investments28.93 Cr.31.67 Cr.20.10 Cr.21.16 Cr.
Net Receivables486.37 Cr.343.64 Cr.354.80 Cr.298.24 Cr.
Long Term Debt262.88 Cr.303.39 Cr.297.83 Cr.296.63 Cr.
Inventory266.69 Cr.312.46 Cr.364.23 Cr.303.05 Cr.
Accounts Payable229.61 Cr.201.15 Cr.160 Cr.164.54 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account